GYNECOMASTIA DURING THERAPY WITH SPIRONOLACTONE

[1] STEROIDAL LACTONES [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (17) : 4808 - 4809

[2] ALDOSTERONE ANTAGONISTS [J]. ARCHIVES OF INTERNAL MEDICINE, 1958, 102 (06) : 998 - 1004

[3] USE OF SPIRONOLACTONE IN RENAL EDEMA - EFFECTIVENESS AND ASSOCIATION WITH HYPERKALEMIA [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 176 (09): : 769 - &

[4] MOYER JH, 1960, EDEMA MECHANISMS MAN

[5] EFFECT OF AN ALDOSTERONE ANTAGONIST ON SODIUM AND POTASSIUM EXCRETION IN PRIMARY HYPERALDOSTERONISM [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1958, 18 (07) : 787 - 789

[6] SMITH WG, 1962, LANCET, V2, P886

[7] STOKES JF, 1962, LANCET, V2, P911

[1] STEROIDAL LACTONES [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1957, 79 (17) : 4808 - 4809

[2] ALDOSTERONE ANTAGONISTS [J]. ARCHIVES OF INTERNAL MEDICINE, 1958, 102 (06) : 998 - 1004

[3] USE OF SPIRONOLACTONE IN RENAL EDEMA - EFFECTIVENESS AND ASSOCIATION WITH HYPERKALEMIA [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 176 (09): : 769 - &

[4] MOYER JH, 1960, EDEMA MECHANISMS MAN

[5] EFFECT OF AN ALDOSTERONE ANTAGONIST ON SODIUM AND POTASSIUM EXCRETION IN PRIMARY HYPERALDOSTERONISM [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1958, 18 (07) : 787 - 789

[6] SMITH WG, 1962, LANCET, V2, P886

[7] STOKES JF, 1962, LANCET, V2, P911